Table 1.

Baseline characteristics of patients and tumors.

	Number	%
Median Age, Range (Years)	71, 58–94
Male/Female	66/6	92/8
Liver Cirrhosis (Yes/No)	64/8	89/11
Etiology (Alcohol/Virus/NASH/Others)	45/7/8/4	70/11/13/6
WHO Performance Status (0/1)	58/14	81/19
BCLC Stage (A/B)	11/61	15/85
Child-Pugh Class (A/B7)	65/7	90/10
Previous Treatment of HCC (Yes/No)	5/67	7/93
Unilobar/Bilobar Disease	63/9	88/12
No. of Nodules (1/2–3/>3)	48/18/6	67/25/8
Median Diameter of Largest Nodule, Range (mm)	55, 13–150
Median Serum AFP, ng/mL (Range)	10, 3–17,660
Median Serum PT, % (Range)	83 (41–100)
Median Serum Bili, µmol/L (Range)	14 (4–48)